About Transonic

Transonic Systems Inc.® was founded in 1983 by R&D scientist/engineer Cornelis (Cor) J. Drost.

As an engineer and scientist at Cornell University in the 1970s, Cornelis (Cor) Drost was tasked to design a better method to measure volume blood flow in physiological models, as the previous methods had limitations. After much study and trial, Cor conceived the design principles for the world’s first transit-time ultrasound flowmeter to measure volume flow in biomedical applications. This was validated by his NIH grant collaborators in Cornell’s Veterinary Physiology Department as accurate and superior to existing methodologies and was soon patented.

Cor wanted to bring this new, more accurate method of measuring volume flow to the world so he founded Transonic in 1983. Transit-time ultrasound technology quickly became recognized as the gold standard for volume flow measurements in research applications, medical devices, and surgical procedures. Our transit-time flow technology has been cited in thousands of studies that include human surgery, research applications, bench validations, life-saving medical devices, and more.

Our measurement tools include intraoperative flowprobes for surgeons, monitors and sensors tailored for hemodialysis and critical care, and specialty sensors customized for original equipment manufacturers.

Our Dedicated Staff

Our staff of 120 dedicated employees includes 100 members at our Ithaca, NY, world headquarters and an international sales force, and support staff at Transonic subsidiaries in the Netherlands, Japan and Taiwan. Transonic is an ISO 13485:2016-Certified Manufacturing Facility.

Our Core Values

Our mission is to advance meaningful measurements. Our promise is precision and accuracy. Our passion is innovation and collaboration. Our commitment is to help our customers meet their measurement challenges with application-specific solutions. Our reward is the knowledge that our products have improved the quality of life for many, have helped save or extend lives and have fostered key scientific discoveries.

Innovation

We have never ceased the pursuit of innovation in the life science research arena.

Collaboration

We are recognized as the world leader in biomedical flow measurement technology and its applications.

Accountability

At Transonic, our name is our reputation. From initial design to production to aftermarket support, we stand by our products.

Responsiveness

We continue to strengthen and expand our international customer service, repair and maintenance teams.

Excellence

Our elegant Flowprobe design and sophisticated meters provide real-time flow measurements in the operating room.

circle graphic to show core values for transonic

History and Milestones

Transonic has made several innovations since our founding. Here are the innovation timelines and milestones for our corporate history, CABG, ventricular assist devices, ESRD circle of care, ECMO, OEM, life science research, and vascular, transplant and neurosurgery.

1980s

1983

Transonic Systems Inc. launched!

1983

First transit-time Flowmeters sold for Life Science Research

1988

Transonic constructs its own building. First Flowmeter cleared by the FDA for clinical use.

1990s

1993

Transonic reaches 50 employees. Construction begins on two-story 24,000 sq ft. addition to Transonic facility.

1997

Transonic receives ISO-9001 certification and CE-Mark registration. Patent & FDA clearance awarded for flow-dilution technique.

1998

Transonic Europe office in Maastricht, Netherlands opens.

1999

Cardiothoracic Systems becomes first USA clinical distributor.

2000s

2006

Transonic Asia office in Taiwan opens.

2007

Endosomatic Systems LLC joins the Transonic team.

2010s

2010

Transonic Japan office in Tokorozawa, Japan opens.

2011

Scisense Systems Inc joins the Transonic team.

2012

Transonic rebrands. 30,000 sq ft Headquarters addition completed.

2017

Nipro Corporation and Transonic Systems announce the formation of a Joint Venture. In this Joint Venture, Transonic’s innovative patient care solutions will be marketed and sold in Japan by Nipro.